NYSE · Medical - Healthcare Information Services

Veeva Systems Inc. (VEEV) Stock

$202.63 +4.20% NYSE: VEEV Healthcare

Veeva Systems Inc. is a leading provider of cloud-based software solutions, exclusively dedicated to the global life sciences industry.

Valuation

MetricValue
Price$202.63
Market Cap$32.92B
P/E Ratio29.62
P/B Ratio3.67
P/S Ratio8.12
EPS (TTM)$5.44
52-Week High$310.50
52-Week Low$148.05
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE12.60%
ROA10.12%
ROCE12.70%
Gross Margin28.67%
Operating Margin28.67%
Net Margin28.44%
Debt/Equity0.01
Current Ratio4.89

Annual Financials (USD)

Metric20222023202420252026
Revenue$1.9B$2.2B$2.4B$2.7B$3.2B
Operating Profit$505.0M$459.0M$429.0M$691.0M$916.0M
Net Profit$427.0M$488.0M$526.0M$714.0M$909.0M
EPS$2.63$3.00$3.22$4.32$5.44
Op Margin27.3%21.3%18.2%25.2%28.7%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$3.8B$4.8B$5.9B$7.3B$9.0B
Total Liabilities$905.0M$1.1B$1.3B$1.5B$1.8B
Cash$1.1B$886.0M$703.0M$1.1B$1.4B
Borrowings$55.0M$61.0M$56.0M$76.0M$96.0M

Latest News

Veeva Systems (VEEV) Could Be 41% Undervalued Following Russell Index Removal Simply Wall St. · Jul 10, 2026 Veeva Systems (VEEV) Launches Veeva EHS For Manufacturing And Testing Teams Simply Wall St. · Jul 9, 2026 2 Reasons to Watch VEEV and 1 to Stay Cautious StockStory · Jul 9, 2026 Veeva Systems (VEEV) Sees a More Significant Dip Than Broader Market: Some Facts to Know Zacks · Jul 8, 2026 Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know Zacks · Jul 8, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$764.0M$780.0M$911.0M$1.1B$1.4B
Investing Cash Flow$-360.0M$-1.0B$-1.1B$-721.0M$-1.1B
Financing Cash Flow$-55.0M$-63.0M$-79.0M$-79.0M$-263.0M
Net Cash Flow$410.0M$-252.0M$-183.0M$414.0M$302.0M
Free Cash Flow$750.0M$767.0M$885.0M$1.1B$1.4B

Valuation & Return Ratios

MetricValue
PEG Ratio1.29
EV / EBITDA29.35
FCF Yield4.91%
Quick Ratio4.89
Interest Coverage
Return 1Y-31.23%
Return 3Y-0.12%
Return 5Y-39.51%

Ownership

Insiders Held8.59%
Institutions Held89.64%
Institutions Float Held98.06%
Institutional HolderSharesReport Date
Blackrock Inc.11,558,8752026-03-31
Vanguard Portfolio Management LLC7,376,0312026-03-31
Vanguard Capital Management LLC6,670,3182026-03-31
Alliancebernstein L.P.6,271,0982026-03-31
Linonia Partnership LP4,924,6262026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAgilent Technologies, Inc. $137.39 -0.85% 25.52 $38.80B 0.59%
ARGXargenx SE $862.93 +0.41% 48.25 $53.99B 0.00%
BDXBecton, Dickinson and Company $168.40 +1.24% 26.08 $61.01B 2.58%
BRKR $62.91 +4.76% 23.24 $9.58B 0.35%
CAHCardinal Health, Inc. $229.12 -1.46% 34.93 $53.66B 0.89%

About Veeva Systems Inc.

Veeva Systems Inc. is a leading provider of cloud-based software solutions, exclusively dedicated to the global life sciences industry. Its extensive operational presence spans across North America, Europe, the Asia Pacific region, the Middle East, Africa, and Latin America. The company's product portfolio is primarily structured around two major offerings. First, the Veeva Commercial Cloud delivers an integrated suite of software, data, and analytics tools designed to optimize commercial operations. This includes vital applications such as Veeva Customer Relationship Management (CRM) and its specialized Medical CRM, Veeva Closed Loop Marketing (CLM), sophisticated analytics via Veeva CRM MyInsights, approved email communication with Veeva CRM Approved Email, digital engagement tools like Veeva CRM Engage, commercial alignment through Veeva Align, event management capabilities with Veeva CRM Events Management, data warehousing solutions (Veeva Nitro), data services (Veeva OpenData, Veeva Link), master data management (Veeva Network), advanced analytical insights (Veeva Crossix, Veeva Data Cloud), and patient engagement platforms (MyVeeva for Patients). Secondly, Veeva Vault provides a robust collection of cloud-native enterprise content and data management applications. These applications are engineered to support both critical commercial functions—encompassing sales, marketing, and medical content and communications—and comprehensive research and development processes, including clinical trials, regulatory compliance, quality management, and patient safety. Beyond its software, Veeva offers a wide array of professional and support services. These range from strategic implementation and deployment planning, project management, and detailed requirements analysis to solution design and configuration. They also include system environment management and deployment, expert consulting for business process transformation related to Veeva solutions, technical guidance on data migration and systems integrations, comprehensive training programs, and ongoing managed services such as outsourced systems administration. Tracing its origins, the company was incorporated in 2007 as Verticals onDemand, Inc., and subsequently rebranded to Veeva Systems Inc. in April 2009. Its corporate headquarters are situated in Pleasanton, California.

Veeva Systems Inc. is led by CEO Peter Gassner, employs 7,291 people, headquartered in Pleasanton, US, publicly traded since 2013.

Veeva Systems Inc. (VEEV) stock trades at $202.63 with a market capitalization of $32.92B. The stock is valued at a price-to-earnings (P/E) ratio of 29.62, price-to-book of 3.67, price-to-sales of 8.12. Over the past 52 weeks the stock has ranged between $148.05 and $310.50, and currently trades 34.7% below its 52-week high.

On profitability, Veeva Systems Inc. generates a return on equity (ROE) of 12.60%, above the typical market average, return on capital employed of 12.70%, an operating margin of 28.67%, a net profit margin of 28.44%.

In its most recent fiscal year, Veeva Systems Inc. reported annual revenue of $3.2B, net profit of $909.0M, revenue has compounded at 16.9% a year over the last five years, profit at 19.1% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of 0.01 — a conservative balance sheet with little leverage risk, a current ratio of 4.89, total assets of $9.0B, $1.4B in cash and equivalents.

VEEV has an average daily trading volume of 3,020,000 shares, a beta of 0.95.

Official website: www.veeva.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides